Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days.
about
Miniature Swine as a Clinically Relevant Model of Graft-Versus-Host DiseaseClinical lung xenotransplantation--what donor genetic modifications may be necessary?Clinical xenotransplantation of organs: why aren't we there yet?Genetically-engineered pig-to-baboon liver xenotransplantation: histopathology of xenografts and native organsSequential analysis of anti-alpha Gal natural antibody-producing B cells in GalT knockout mice in cyclophosphamide-induced tolerance.Transient transmission of porcine endogenous retrovirus to fetal lambs after pig islet tissue xenotransplantation.Hepatic function after genetically engineered pig liver transplantation in baboons.Clinical pig liver xenotransplantation: how far do we have to go?Up to 9-day survival and control of thrombocytopenia following alpha1,3-galactosyl transferase knockout swine liver xenotransplantation in baboonsImmunobiology of liver xenotransplantation.Increased transfusion-free survival following auxiliary pig liver xenotransplantation.The Effects of Exogenous Administration of Human Coagulation Factors Following Pig-to-Baboon Liver XenotransplantationPig Liver Xenotransplantation: A Review of Progress Toward the Clinic.Cytokine profiles in Tibetan macaques following α-1,3-galactosyltransferase-knockout pig liver xenotransplantation.Overcoming the barriers to xenotransplantation: prospects for the futureBarriers to the successful treatment of liver disease by hepatocyte transplantation.Progress in pig-to-non-human primate transplantation models (1998-2013): a comprehensive review of the literatureGenetic modification of xenografts.Human CD59 incorporation into porcine endogenous retrovirus particles: implications for the use of transgenic pigs for xenotransplantationXenotransplantation and other means of organ replacement.Production of multiple transgenic Yucatan miniature pigs expressing human complement regulatory factors, human CD55, CD59, and H-transferase genesPhysiological aspects of xenotransplantation, 2001.Generation of a felinized swine endothelial cell line by expression of feline decay-accelerating factorWhich patients first? Planning the first clinical trial of xenotransplantation: a case for cardiac bridging.Pig liver xenotransplantation as a bridge to allotransplantation: which patients might benefit?Nucleotide metabolic mismatches in mammalian hearts: implications for transplantation.Porcine alanine transaminase after liver allo-and xenotransplantationExperimental hepatocyte xenotransplantation--a comprehensive review of the literature.Genetically Modified Pigs as Organ Donors for Xenotransplantation.British citizens in a regional community of southeastern Spain with a pre-clinical organ xenotransplantation program. A study of attitude toward xenotransplantation.Reference values of biochemical and hematological parameters for Guizhou minipigs.Level of acceptance of a clinical xenotransplantation program among personnel in solid organ transplant-related services
P2860
Q26782509-7433FCA6-7722-4B2B-A6D0-93D890122636Q26823663-4DC8B101-C7F0-4F31-A45E-6DD369AF1E9DQ28221527-6148BFE5-35D6-412B-9ADD-FC83C7F58ED0Q28732872-2911EE13-4B6D-42A2-AE73-44FBDEA4304AQ33246284-3381A8B9-90AB-4054-844F-5BD384032DDAQ33390100-E734CC25-330C-486D-B07D-1C77547E22CEQ33390545-A159B44A-D863-4D98-8BE8-500826A25C88Q33395889-3ECD1C35-8FC9-4772-AF65-6655CFAF196BQ33402895-D1BCCB9F-D373-4D8B-9EC9-8989B9942C64Q33403888-B5105D57-2A66-4EE8-9BD1-A65DA6606862Q33417115-B27AAF01-AE79-484B-AE2C-161229F84F94Q33427920-8FFFD308-D3C4-48F4-8910-05C7A9EBED9DQ33433973-F39D71E0-F5D8-46BB-A96D-3DB4B0DA6CAEQ33443697-B0A19E98-0C09-470F-9B7D-07585B0F5B74Q33801035-B4D0B674-E574-430B-885C-2C577E2EDBDDQ34091618-CB5F3335-C0E2-4C27-AB73-A6BD2BC89EA8Q34250530-BE39628B-C419-4E72-B9D9-190861882396Q34311785-ADC2C0F4-DF37-473E-8D7C-6A02815E5609Q34331007-0BC35FA8-DE74-42AC-A8C7-3379CA3A78BFQ34572172-196214FC-2D24-4206-ADEF-43AC4D3214C7Q34737368-34C8A5B9-F536-4612-A42C-EB11B6D7B52FQ34801562-AC8AC53C-5D1B-4166-AA4F-95467D7655F0Q35559356-A034DFF7-DC32-4BE4-8F65-20860D6BFC61Q36088303-A6424CCB-7175-4054-8B04-C33D49652C8DQ37424698-DF6F3CD8-6173-473E-B0EA-419208E2ADCFQ37661241-E4889877-EB5F-4C6E-9192-7568D2324D53Q37987618-E2FC9D11-6297-4577-9A2F-B6C9CA7954F8Q38463980-9596F8F4-B3A0-45E3-B2F3-E68FEC1F23A9Q39429841-799E16C8-B411-461B-80A2-C6F879C695D0Q40214687-FC3F9CB3-010D-4845-A1DD-CD3A1E4FB4C4Q43842412-5017F325-0124-47D7-97C1-35055C602A36Q57583719-25A9FBF6-D268-4C23-B20F-3861AAB495E9
P2860
Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Life-supporting human compleme ...... uman primate for up to 8 days.
@en
Life-supporting human compleme ...... uman primate for up to 8 days.
@nl
type
label
Life-supporting human compleme ...... uman primate for up to 8 days.
@en
Life-supporting human compleme ...... uman primate for up to 8 days.
@nl
prefLabel
Life-supporting human compleme ...... uman primate for up to 8 days.
@en
Life-supporting human compleme ...... uman primate for up to 8 days.
@nl
P2093
P50
P1433
P1476
Life-supporting human compleme ...... human primate for up to 8 days
@en
P2093
A S Vizcaino
C G Palenciano
P304
P356
10.1097/00007890-200010150-00001
P577
2000-10-01T00:00:00Z